Prime Medicine (PRME) Change in Acquisitions & Divestments (2021 - 2025)
Historic Change in Acquisitions & Divestments for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $42.4 million.
- Prime Medicine's Change in Acquisitions & Divestments fell 3078.14% to $42.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.6 million, marking a year-over-year decrease of 5906.46%. This contributed to the annual value of $204.2 million for FY2024, which is 5404.81% up from last year.
- As of Q3 2025, Prime Medicine's Change in Acquisitions & Divestments stood at $42.4 million, which was down 3078.14% from $11.2 million recorded in Q2 2025.
- Prime Medicine's 5-year Change in Acquisitions & Divestments high stood at $72.5 million for Q1 2024, and its period low was $3.0 million during Q1 2025.
- Its 5-year average for Change in Acquisitions & Divestments is $31.2 million, with a median of $31.2 million in 2022.
- Per our database at Business Quant, Prime Medicine's Change in Acquisitions & Divestments surged by 23368.33% in 2023 and then crashed by 9586.21% in 2025.
- Quarter analysis of 5 years shows Prime Medicine's Change in Acquisitions & Divestments stood at $13.0 million in 2021, then soared by 92.31% to $25.0 million in 2022, then soared by 90.14% to $47.5 million in 2023, then crashed by 30.79% to $32.9 million in 2024, then increased by 28.97% to $42.4 million in 2025.
- Its Change in Acquisitions & Divestments was $42.4 million in Q3 2025, compared to $11.2 million in Q2 2025 and $3.0 million in Q1 2025.